ABOUT THE COMPANY

ABOUT THE COMPANY

Circularity Healthcare — Improving Lives By Improving Blood Flow

Doesn't Your Health Deserve D’OXYVA®?

Click to purchase the only fully non-invasive, completely painless, over-the-skin CO2 delivery solution validated to significantly improve microcirculation.
Welcome to

Improving Lives by Improving Blood Flow

 

Since 2011, Circularity has provided skin delivery products, cardiovascular treatments, diabetes management, and diabetes pain relief care centers.

Circularity Healthcare, LLC (Circularity™) — headquartered in Los Angeles, California, USA — is an emerging biotech world-leader in proprietary circulatory health and non-invasive delivery technologies.

We are committed to radically changing the standard of care and helping improve lives by developing, manufacturing, and marketing wellness, medical devices, consumer health, and pharmaceutical products.

Circularity operates a state-of-the-art global supply chain and Quality Management System (QMS) for manufacturing and order fulfillment around the world.

For example, Life Sciences Outsourcing, Inc. in Brea, CA is one of Circularity’s contracted GMP-certified facilities for assembly and order fulfillment.

Circularity facilities are located in California, New Jersey, Arizona, Taiwan, Indonesia, Vietnam, Malaysia, Netherlands, Slovakia, and Hungary.

Circularity’s Quality Management System was established by global regulatory firm, the Emergo Group in 2013.

One of the largest and most diversified global law firms K&L Gates has been Circularity’s main legal representation in intellectual property and business law from our inception in 2011.

Big Four accounting firm KPMG has conducted Circularity’s equity valuations and business plan analyses.

Circularity works with other leading institutions to bolster its global growth.

Circularity has a certificate of registration to IS EN ISO13485:2012 (European Union) and ISO13485:2003 under CMDCAS (Canada) it has been implementing since 2013.

Circularity’s flagship product, D’OXYVA, is a CE-marked medical device (Class I – Non-Significant Risk).

Circularity is seeking approvals via the U.S. FDA and in other countries for delivery of Medical Gases, such as Medical Carbon Dioxide (USP UN1013), via novel patented and patent-pending non-invasive skin delivery route D’OXYVA as solution for various widespread conditions.

Several major long-term trends are reshaping the healthcare industry worldwide:

  • The movement towards the outpatient setting to encourage lowering healthcare budgets;
  • Decreasing reimbursement for hospital stays, hospital outpatient centers and treatments;
  • Increasing demand for proactive, patient-involved post-hospitalization care; and,
  • Increasing the role of telemedicine and telediagnostics to track patient progress and satisfaction.

In addition, blockbuster pharmaceutical patents are expiring quickly, new medicine breakthroughs are decreasing, and profits are diminishing partly because of generics and the increasing cost of research and development.

The markets for health care solutions are driven by a high demand for minimally or non-invasive, ultra-portable applications with low-cost, low-risk, low-regulatory requirements and short time to market that require little or no reimbursement.

D’OXYVA meets these requirements and much more.

OUR VALUES

Our people consider the following values are essential to realizing our mission as an effective and efficient organization.

We at Circularity believe in a long-sought-after goal in health care: Access to a single health application that solves most short- and long-term health issues quickly, affordably, without pain, and without compromising other health aspects.

Therefore, our mission is to design, develop, manufacture, and market proprietary, advanced, and affordable technologies that significantly improve quality of life by improving some of the most essential physiological functions in the body.

 
 
 

ETHICS

 
 

Our guiding objective is to serve those who empower our company to deliver the best solutions to patients and consumers who benefit from our products — including our primary stakeholders, the our recommending doctors, and the various distribution channels.

 

ACCOUNTABILITY

 

We do what we say and we say what we do to, empowering our company and our people to excel by taking absolute responsibility for every product, services, and solution.

CREATIVE ENTREPRENEURSHIP

 
 

We always listen to those with diverse backgrounds to consistently envision  and create meaningful solutions that build value for all people engaged with our company.

RESOURCEFULNESS

 
 

We have built our company on the principle of innovative, lean, and collaboratively outsourced partnerships.

We provide affordable products with a wide variety of benefits to people worldwide.

We are conscientious of the bottom line that enables us safe, steady growth.

QUICK TO MARKET

 
 

Stakeholders praise our agility and precision as we tackle the unique challenges in a global business environment.

TRANSPARENCY

 
 

We share openly and directly with all stakeholders our company’s activities, including the potential benefits and risks of the products, services, and solutions we offer.

TEAMWORK & TALENT DEVELOPMENT

 
 

We are committed to building a world-class team that functions with dynamic flexibility, improves through collaborative support, and trains using the best-in-practice tools and techniques.

 

Doesn't Your Health Deserve D’OXYVA®?

Click to purchase the only fully non-invasive, completely painless, over-the-skin CO2 delivery solution validated to significantly improve microcirculation.